Featured Post from University of Delaware

Armed with a new NIH grant, UD's Day Lab targets difficult-to-treat diseases with breakthrough therapies

Oct 31, 2023

2 min

Emily Day


The University of Delaware's Day Lab, led by associate professor Emily Day, is conducting innovative research on high-precision therapies using unique nanoparticles. With a recent R35 grant from the National Institutes of Health (NIH), the lab aims to advance the design and use of nanoparticles for managing various diseases, including cancers, blood disorders, and reproductive health conditions. The lab specializes in developing nanomaterials with properties that allow them to target specific cells, evade immune detection and deliver therapeutic cargo effectively. The focus is on understanding the interaction of these nanoparticles with cells and tissues to improve the study, diagnosis, and treatment of diseases.


What sets Day's group apart is its ability to bridge the gap between fundamental research and practical applications in nanomedicine. The lab received an NIH Maximizing Investigators' Research Award (MIRA) to support their research for five years, providing stability and flexibility to pursue breakthroughs in overcoming biological barriers to nanoparticle delivery. Key research questions include understanding protein corona-mediated immune clearance and how nanoparticles cross blood vessel walls, addressing challenges in particle distribution and targeting. Overcoming these barriers could significantly enhance the clinical impact of nanomedicine and improve the treatment of various diseases.


While the lab's research is fundamental, its implications extend broadly across the field of nanomedicine. The discoveries made, particularly in membrane-wrapping research, may have applications in enhancing the effectiveness of treatments, such as mRNA COVID vaccines, by preventing clearance from the body.


Researchers are hopeful that their work will contribute to advancements in targeted therapies, making them more widely available for various diseases.


To arrange an interview with Day, visit her profile and click the "contact" button.

Connect with:
Emily Day

Emily Day

Associate Professor, Biomedical Engineering

Prof. Day engineers drug & biomolecule nanocarriers for targeted treatment of cancers, blood disorders, and reproductive health conditions.

Precision MedicineDrug DeliveryTranslational ResearchGene RegulationPhototherapy

You might also like...

Check out some other posts from University of Delaware

1 min

Deadly flash flooding in Texas was forecasted years ago

The catastrophic flooding of the Guadalupe River in Kerr County, Texas, took place at lightning speed, catching everyone off guard. But the University of Delaware's Jennifer Horney says the risk of flash flooding in the area has been increasing for more than two decades. Horney, an epidemiologist and disaster researcher at the University of Delaware, studied flash flooding in that specific area while at Texas A&M University. She can discuss the following: • This area of Central Texas was designated as “Flash Flood Alley” in 2005 by the Flood Safety Education Program. It has long had high risk from flash flooding, which have been predicted to increase in intensity. • Flash Flood Alley is the area along the Balcones Escarpment, with river valleys and steep limestone cliffs. Extreme rainfall events – the heaviest 1% of all events – have increased in frequency and magnitude by 30% since 1960. • Urbanization and population growth in this area put more people at risk and the annual number of flood fatalities in Texas typically exceeds that of all other states. Several gaps in public risk perception persist even as risks increase with few understanding the life-threatening risks of these events. To arrange an interview with Horney, visit her profile and click on the "contact" button; or contact UD media relations.

1 min

Pandemic deepened health gaps for people with disabilities, study finds

A new peer-reviewed study published in the American Journal of Preventive Medicine reveals that U.S. adults with disabilities experienced significant declines in preventive cardiovascular screenings during the COVID-19 pandemic — and continued to face cost-related barriers to care, even after accounting for economic disruptions. Using nationally representative data from more than 150,000 adults between 2019 and 2023, the study highlights how routine care like blood pressure, cholesterol and glucose screenings dropped most sharply for those with cognitive, physical, or multiple disabilities. Adults with disabilities were also more likely to report delaying or missing care due to cost. These findings underscore persistent health inequities and the urgent need for inclusive public health strategies, especially for populations already at greater risk for cardiovascular disease. Why it matters: Cardiovascular disease remains the leading cause of death in the U.S. Adults with disabilities face higher risks and more barriers to care — making consistent preventive screenings essential. This study offers the first detailed, post-pandemic national look at how different disability groups were affected, with implications for future policy and healthcare reform. For more information on the study and to speak to experts, contact mediarelations@udel.edu. 

1 min

Food is medicine, and this professor has the research to prove it

For more than 20 years, Dr. Allison Karpyn has worked to understand and address food insecurity in America and beyond — studying how communities access healthy food, how policy shapes those opportunities and how local partnerships can make meaningful change. A professor in the University of Delaware’s College of Education and Human Development and co-director of its Center for Research in Education and Social Policy, Karpyn has published extensively on topics including food deserts, healthy corner store initiatives, school nutrition programs and strategies to bring farmer’s markets to underserved areas. Her work, which blends rigorous research with community-based implementation, has appeared in leading journals such as Pediatrics, Preventive Medicine and Health Affairs. Karpyn has also worked directly with nonprofit organizations, government agencies and retailers to pilot and evaluate programs designed to increase access to high-quality food in low-income neighborhoods. Her focus is on actionable, data-informed solutions to persistent challenges — from childhood hunger to structural barriers in the food supply system. Now, Karpyn’s expertise is being tapped as part of Delaware’s new Food is Medicine Committee, a statewide initiative under the Delaware Council on Farm and Food Policy. The committee seeks to connect nutrition and health care to improve outcomes, lower costs and strengthen local food systems — goals that align closely with Karpyn’s career-spanning mission. For journalists exploring food policy, hunger, public health and the future of food access, Karpyn is a key source of insight, research and real-world perspective. She can be contacted by clicking her profile. 

View all posts
Powered by